Reproductive Medicine Specialist
Dr. Demián
Glujovsky
Scientific Director, CEGYR · Buenos Aires, Argentina
Reproductive Medicine Specialist
Scientific Director, CEGYR · Buenos Aires, Argentina
Years in reproductive medicine
Scientific publications
Pregnancy rate per euploid embryo transfer
CEGYR: first IVF center in Argentina
Biography
Dr. Demián Glujovsky is the Scientific Director of CEGYR (Eugin group) in Buenos Aires — the first IVF center in Argentina, founded in 1983. With over 20 years of clinical experience, he has helped thousands of patients from Argentina and around the world achieve their goal of having a child.
What distinguishes Dr. Glujovsky’s practice is the combination of scientific rigor with genuine personal involvement. He is involved from the first message — reviewing your case, designing your treatment plan, and remaining available throughout the process. You work with one doctor, not a rotating team.
His academic work is anchored in the Cochrane Collaboration, the world’s most rigorous network for evidence-based medicine. As an editor for the Cochrane Gynaecology and Fertility Group, he contributes to the systematic reviews that define global clinical standards in reproductive medicine. His research is cited internationally and spans topics from ovarian stimulation, DuoStim, PGT-A, endometrial receptivity, and embryo quality to patient experience and quality of life, and strategies to reduce patient dropout.
Dr. Glujovsky trained at Reproductive Medicine Associates of New Jersey (RMA NJ) and Columbia University in New York City — two of the leading reproductive medicine centers in the United States — and holds a Master’s degree in Clinical Effectiveness from the University of Buenos Aires with the academic support of the Harvard School of Public Health.
He conducts consultations both in person and by video call, and works directly with international patients in English throughout their entire treatment — from the first message to the last transfer.





Credentials & Affiliations
Medical degree with Honors. Specialization in Gynecology and Obstetrics, CEMIC.
Clinical and academic training at two of the leading reproductive medicine centers in the United States.
Graduate degree in clinical effectiveness and evidence-based medicine, developed with academic support from Harvard.
Editor of the Cochrane Gynaecology and Fertility Group — the global gold standard for evidence-based medicine. His systematic reviews shape clinical practice internationally.
CEGYR (Viamonte 1432, Buenos Aires) performed the first IVF in Argentina in 1983. Dr. Glujovsky leads its scientific direction.
Author and co-author of over 50 publications in international journals including Human Reproduction, Fertility and Sterility, and BJOG.
Fertility treatment is not only a medical process — it is one of the most emotionally significant experiences a person can go through. Our mission is to provide the highest quality reproductive medicine combined with the kind of personal care that makes a real difference during a difficult journey.
Dr. Glujovsky believes that patients deserve full transparency: honest success rates, clear explanations of every option, and an honest assessment of what is and isn’t known. Evidence-based medicine means making decisions based on the best available science — not on habit, commercial incentives, or untested promises.
Evidence first
Every recommendation is grounded in the best available scientific evidence, not in protocol or habit.
Radical transparency
Honest success rates, honest prognoses, and honest conversations about what treatment can and cannot achieve.
One doctor, start to finish
Dr. Glujovsky is personally involved from the first message to the last transfer — no rotating teams.
Personalized plans
No two patients are the same. Treatment is designed around your biology, your history, and your priorities.
Contact
Dr. Glujovsky will review your history, explain your options honestly, and tell you exactly what he believes is the right path for you — not a generic protocol. Initial consultations can be in person or via video call from anywhere in the world.